Restenosis Clinical Trial
Official title:
Healing Responses After Treatment of Bare Metal Stent Restenosis With Implantation of an Everolimus-eluting Xience V Stent Versus Use of a Paclitaxel-eluting Balloon: Optical Coherence Tomography Study
Different healing responses after treatment of bare metal stent restenosis with implantation of an everolimus-eluting Xience V stent (Abbott Vascular) versus use of a paclitaxel-eluting SeQuent Please balloon (BBraun): an optical coherence tomography study. A prospective, single-centre, randomized clinical trial with clinical, angiographic and OCT follow-up at 9 months.
Background: The optimal treatment of bare metal stent restenosis (implantation of a drug-eluting stent, simple balloon dilatation, CABG) is still not defined. The most used option nowadays is the implantation of a drug-eluting stent (DES). However, this procedure implies application of a double metal layer in the vessel wall, which is linked to delayed healing. Furthermore there might be a higher risk of malapposition of both struts of the bare metal and the newly implanted drug-eluting stents. These phenomenon's might give rise to an increased risk of stent thrombosis in this patient population. Recently, drug-eluting balloons (DEB) were proposed as a new treatment strategy for bare metal stent restenosis. The initial results of this technique look promising. Aim: To compare healing processes after treatment of BMS ISR with balloon dilatation using DEB versus implantation of DES. Methods: 50 patients with BMS restenosis (SVG and bifurcation lesions will be excluded) will be randomized into two treatment groups: SeQuent Please drug-eluting balloon dilatation (group I) versus implantation of an everolimus-eluting Xience V stent (group II). At 9 months, a control angiography with OCT pullback of the treated segment is planned. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01970579 -
Clinical Trial on Peripheral Arteries Treated With SeQuent® Please P Paclitaxel Coated Balloon Catheter
|
Phase 3 | |
Completed |
NCT01861860 -
OPtimized Stenting Using Intravascular Ultrasound(IVUS) in Long lEsion: Rationale for Simplified criteriA
|
N/A | |
Completed |
NCT01722877 -
JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions
|
N/A | |
Recruiting |
NCT00774917 -
Numen Stent Assessment Using OCT Technique in a Single Center Study
|
Phase 2/Phase 3 | |
Completed |
NCT00493597 -
Blood Endothelium Progenitor Cells and Dendritic Cells as Predictive Biomarkers of In-stent Restenosis
|
||
Completed |
NCT00647504 -
Prospective Clinical Observational Registry Including Consecutive Patients With In-stent Restenosis or Stent Thrombosis
|
N/A | |
Not yet recruiting |
NCT01476020 -
Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogrel
|
Phase 3 | |
Terminated |
NCT00780156 -
The ITALIC Study: Is There A LIfe for Drug-eluting Stents (DES) After Discontinuation of Clopidogrel
|
N/A | |
Terminated |
NCT00712257 -
Study to Evaluate the Safety and Performance of Spectranetics Laser w/Adjunct PTA and Gore Viabahn Endoprosthesis for Treatment of SFA Instent Restenosis
|
N/A | |
Recruiting |
NCT03613337 -
Effect of Smoking Status and Genetic Risk Factors on Restenosis and Efficacy of Clopidogrel After de Novo Percutaneous Coronary Intervention
|
||
Completed |
NCT03332264 -
Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions
|
N/A | |
Completed |
NCT02063672 -
Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis
|
N/A | |
Recruiting |
NCT05451368 -
Neointimal Features in Patients With Restenosis of Calcified Lesions
|
||
Completed |
NCT02649946 -
Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
|
N/A | |
Completed |
NCT01632371 -
Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4
|
Phase 4 | |
Completed |
NCT00798954 -
Treatment of Bifurcation Lesions by SINGLE STENT and KISSing Balloon Trial
|
Phase 4 | |
Withdrawn |
NCT03146221 -
Search for Restenosis Markers in Lower Limb Arteritis
|
N/A | |
Completed |
NCT02790606 -
Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)
|
N/A | |
Completed |
NCT01405248 -
Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting
|
Phase 3 | |
Completed |
NCT00987324 -
Efficacy Study of Paclitaxel-eluting Balloon, -Stent vs. Plain Angioplasty for Drug-eluting Stent Restenosis
|
Phase 4 |